This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

CosMX-ATL patent disputes continue amid rivalry over lithium-polymer batteries

By MLex Staff ( November 7, 2024, 07:33 GMT | Insight) -- In the latest development of a protracted three-year-long patent dispute involving multiple lawsuits between Zhuhai CosMX Battery and its Chinese rival Amperex Technology Limited, a recent ruling by a Chinese court has determined that CosMX infringed ATL's patent related to rechargeable battery cells. In a disclosure to the stock exchange on Tuesday, CosMX revealed that it had received a first-instance judgment from the Fuzhou Intermediate Court that found the company accountable for infringing its rival’s invention patent.A recent ruling by a Chinese court has determined that Zhuhai CosMX Battery infringed the patent of its rival Amperex Technology Limited, or ATL, in the latest development in a protracted three-year-long patent dispute involving multiple lawsuits between the two companies....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections